Acorda Therapeutics
ACOR
#11271
Rank
โ‚น76.08 M
Marketcap
โ‚น61.25
Share price
0.00%
Change (1 day)
-95.49%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2024 (TTM): -โ‚น4,167

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น4,662. In 2022 the company made an earnings per share (EPS) of -โ‚น8,005 an increase over its 2021 EPS that were of -โ‚น18,497.

EPS history for Acorda Therapeutics from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น4,167
2022-โ‚น8,005-56.72%
2021-โ‚น18,497-16.13%
2020-โ‚น22,055-65.51%
2019-โ‚น63,942-898.61%
2018โ‚น8,007-114.88%
2017-โ‚น53,823536.84%
2016-โ‚น8,451-392.31%
2015โ‚น2,891-39.53%
2014โ‚น4,7824.88%
2013โ‚น4,559-89.54%
2012โ‚น43,592

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚น243.72-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-โ‚น18.53-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-โ‚น484.42-89.61%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
-โ‚น8.34-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA